Trial intelligence / Profile preview

FOCUS: Fluorouracil, Oxaliplatin and Irinotecan Sequencing in Advanced Colorectal Cancer

NCT00008060Phase 3Completed

Sponsor
Medical Research Council
Start
May 2000
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 3 trial of irinotecan, oxaliplatin in colorectal cancer (CRC), sponsored by Medical Research Council. Started May 2000; status: completed.

02

Drugs

irinotecanoxaliplatin
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00008060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00008060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call